CoronaryAtlas logo
CoronaryAtlas
Interleukin-2
Pathway / Plaque inflammation

Interleukin-2

IL2protein

IL-2 elevation promotes T-cell-mediated vascular inflammation and is associated with acute coronary syndrome.

Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationalePro-inflammatory Th1 cytokine; elevated in ACS and STEMI.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000109471

Type I vs Type II discrimination

ScoresIndeterminate
R — rupture / Type-I
67
C — confounder / Type-II
44
A — assay feasibility
68
E — evidence strength
58
T1DI (composite)
24
Specificity differential (R−C)+23
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
3hypovolemia / dehydrationmag 1
4tachyarrhythmiamag 2
5hypoxemia / respiratory failuremag 1
6hypertensive emergencymag 1
7high-demand / peri-operative stressmag 1
Coverage: 6/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 15 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(10)